Gangwal Healthcare

India

CPhI India 2024

Booth #8.Q10

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : DiCOM-DC® SR300

Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Grade : Oral

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Brand : DICOM-DC® SR300

Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Vilanterol to address drug delivery challenges on PharmaCompass.

Vilanterol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers

8 USDMF

4 EU WC

1 KDMF

9 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

10 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers

6 FDA Orange Book

30 Europe

5 South Africa

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH

RELATED EXCIPIENT COMPANIES

2 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 DFE Pharma

14 Kerry

7 Microlex e.U

2 Pluviaendo

1 Prachin Chemical

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Sigachi Industries

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders

8 Lubricants & Glidants

8 Direct Compression

5 Co-Processed Excipients

4 Granulation

1 Controlled & Modified Release

1 Emulsifying Agents

1 Thickeners and Stabilizers

1 Parenteral

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

42 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

30 Finished Drug Prices

10 Annual Reports

MARKET PLACE

2 APIs

PATENTS & EXCLUSIVITIES

110 US Patents

4 US Exclusivities

REF. STANDARDS & IMPURITIES

10 Others

Filters

Vilanterol

01

Gangwal Healthcare